Mr Tim Dudderidge
Consultant Urologist
MB ChB, MSc, FRCS (Urol)
Mr Tim Dudderidge
Tim is a Consultant Urological Surgeon and lead of prostate cancer surgical trials at University Hospital, Southampton. Tim specialises in prostate cancer and is one of a handful of clinicians combining an interest in imaging and precision diagnostics with skills in both focal therapy and robotic surgery for prostate cancer.
He received his Doctorate of Medicine in 1998, and more recently, a Research Doctorate, both from the University of Bristol. He trained in London and spent time undertaking research at University College London, gaining an MSc degree. He went through urological training at all the leading cancer centres including Kings College Hospital, University College Hospital, Imperial Healthcare and the Royal Marsden Hospital where he also worked as a consultant. Tim was awarded a Royal College of Surgeons Uro-Oncology Fellowship at Imperial in 2009 and subsequently was the UK’s First Robotic Surgery Fellow at Royal Marsden Hospital.
Professional Qualifications
- MBChB, University of Bristol – 1998
- MSc Urology, University College London – 2003
- MD, University of Bristol – 2014
- Royal College of Surgeons Uro-Oncology Fellowship, Imperial College London – 2010
- Robotic Surgery Fellowship, Royal Marsden Hospital
- Visiting Fellowship (robotic cystectomy), Karolinska Hospital Stockholm
Professional Affiliations
- General Medical Council
- Royal College of Surgeons of England
- British Association of Urological Surgeons, Uro-oncology and Endo-urology
- BAUS Section of Academic Urology
- Medical Protection Society
- High-Intensity Focused Ultrasound (HIFU) Users Group
Current Appointment
- University Hospital Southampton, Southampton
- Spire Southampton Hospital, Southampton
- Sarum Road Hospital, Winchester
Previous Appointments
- University College Hospital, London
- King’s College Hospital, London
- Imperial College Healthcare, London
- Royal Marsden Hospital, London
Awards and Distinctions
- Royal College of Surgeons Uro-Oncology Fellowship, 2009
Selected Peer Reviewed Publications
- A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. European Urology. 2018.
- High-intensity focused ultrasound focal therapy for prostate cancer. Trends in Urology and Men’s Health. 2020.
- Evaluation of functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) procedure in men with primary localized, non-metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry. BJU International. 2020.
- Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis. Journal of Medical Economics. 2023.
Any questions?
If you’ve got any questions about your prostate cancer diagnosis or want to know more about HIFU or NanoKnife, don’t hesitate to get in touch with our friendly, knowledgeable team.